Tag: AMAG pharmaceuticals

September 28, 2020

What is In-Licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
March 8, 2019

AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena

AMAG Pharmaceuticals (NASDAQ:AMAG) has announced topline results from its PROLONG trial evaluating Makena in patients with a history of a...
September 26, 2018

AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia

AMAG Pharmaceuticals (NASDAQ:AMAG) today announced it has acquired global rights to develop and market digoxin immune Fab (ovine) (DIF), a polyclonal...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 26, 2018

AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration

AMAG Pharmaceuticals (NASDAQ:AMAG) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration...
March 18, 2018

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...